Pfizer Under Fire and an Alibaba Beatdown
Eyebrows raised on Wall Street as Pfizer’s CEO sold 60% of his stock the same day his company announced positive COVID vaccine news. What to make of the timing of that trade. Plus Alibaba posting record sales during its Singles Day holiday, but is there trouble ahead for the Chinese e-commerce giant? Hosted by…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from CNBC's "Fast Money"
See all episodes →Yields Spike As Consumer Confidence Drops… And Altman Weighs In On AI Pacing 9/29/26
Rates Keep Rising… And The Quiet Playbook For A Noisy Market 9/28/26
Market Resilience Despite Surge In Yields… And Options Action Ahead Of Micron Results 9/25/26
Similar episodes from other shows
More like CNBC's "Fast Money" →
Alibaba Shakes Things Up
Pfizer's covid-19 vaccine, China looks at fintech regulation, and Lyft President John Zimmer on the future of gig work
Know Your IPO: Snowflake, GW Pharmaceuticals CEO & Stocks Moving On Vaccine News
Covid-19 vaccine makers seek protections, US homebuilder stocks rise, Ant IPO
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.